GlassScriptPhysician profile
Manish R Parikh
NPI 1275580359
$9,745.28
in general payments reported to CMS, 2019-2025
50 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,328 · 2020: $1,974 · 2021: $1,564 · 2022: $1,260 · 2023: $461 · 2024: $643 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,911.34 | 2020-2025 | Barostim Neo System |
| Abbott Laboratories | $840.60 | 2019-2024 | Jot Dx |
| Atricure, INC. | $619.98 | 2021-2022 | |
| Covidien LP | $612.93 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $547.58 | 2019-2020 | |
| Amarin Pharma, INC. | $463.90 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $417.25 | 2019-2023 | Xarelto |
| Amgen INC. | $415.41 | 2019-2022 | |
| Novo Nordisk INC | $414.65 | 2019-2021 | |
| Pfizer INC. | $395.80 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $330.66 | 2019-2021 | |
| Astellas Pharma US INC | $301.60 | 2019-2021 | |
| Allergan, INC. | $228.12 | 2019-2020 | |
| Zoll Respicardia, INC. | $212.88 | 2020 | |
| Mylan Specialty L.P. | $184.99 | 2019-2020 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.